Mergers & Acquisitions - Pharmaceutical, North America

Filter

Popular Filters

1 to 25 of 37 results

Retrophin to acquire Kyalin Biosciences; in-licenses Syntocinon

13-12-2013

In a second takeover bid within a matter of months, USA-based Retrophin announced that it will acquire…

Kyalin BiosciencesLicensingMergers & AcquisitionsNeurologicalNorth AmericaNovartisPharmaceuticalRetrophinSyntocinonWomen's Health

Emergent BioSolutions to acquire Cangene for $222 million

12-12-2013

Taking a significant step to solidify its leadership position in the growing biodefense market, US vaccine…

CangeneEmergent BioSolutionsMergers & AcquisitionsNorth AmericaPharmaceuticalVaccines

FTC highlights focus on health care markets competition before Judiciary subcommittee

17-11-2013

The USA’s Federal Trade Commission described its ongoing efforts to protect competition and consumers…

HealthcareLegalMergers & AcquisitionsNorth AmericaPharmaceutical

US FTC finalizes amendments to the premerger notification rules on patent right transfers

07-11-2013

The US Federal Trade Commission yesterday (November 6) issued final changes to the premerger notification…

LegalMergers & AcquisitionsNorth AmericaPatentsPharmaceutical

Oxygen Biotherapeutics signs agreement to acquire Phase III cardiac drug from Phyxius Pharma

22-10-2013

US drug developer Oxygen Biotherapeutics has signed a Definitive Agreement to acquire certain assets…

Cardio-vascularLevosimendanLicensingMergers & AcquisitionsNorth AmericaOxygen BiotherapeuticsPharmaceutical

Bayer and Onyx file for EU and US approval for expanded use of Nexavar; completes Steigerwald buy

01-07-2013

German drug major Bayer (BAYN: DE) and US partner Onyx Pharmaceuticals (Nasdaq: ONXX) have filed for…

BayerBiotechnologyEuropeMergers & AcquisitionsNexavarNorth AmericaOncologyOnyx PharmaceuticalsPharmaceuticalRegulationSteigerwald

Briefs: Depomed drops Sefelsa after CRL: Sun Pharma stalking Meda?

03-06-2013

US specialty drugmaker Depomed (Nasdaq: DEPO) says that Food and Drug Administration issued a complete…

DepomedMedaMergers & AcquisitionsMetabolicsNorth AmericaPharmaceuticalRegulationResearchSefelsaSun Pharmaceutical Industries

Sanofi sells US drug rights to Covis; Prices bond issue

08-04-2013

Privately held Swiss specialty drug firm Covis Pharma has reached agreement with a USA-based unit of…

Covis PharmaFinancialMergers & AcquisitionsNorth AmericaPharmaceuticalSanofi

Briefs: Sanofi to up stake in Regeneron; Bayer files for riociguat approval

12-02-2013

US biotech Regeneron Pharmaceuticals (Nasdaq: REGN) saw its shares rise 4.8% to $173.84 in early trading…

BayerBiotechnologyEuropeFinancialMergers & AcquisitionsNorth AmericaPharmaceuticalRegeneronRegulationRespiratory and PulmonaryriociguatSanofi

Tranzyme exploring options, including sale of the firm; is Ache up for sale?

11-02-2013

Following two recent R&D pipeline disappointments, the board of directors of US biotech firm Tranzyme…

Ache Laboratorios FarmaceuticosBiotechnologyMergers & AcquisitionsNorth AmericaPharmaceuticalSouth AmericaTranzyme

Watson acquires Uteron Pharma; confirms Opana patent challenge

24-01-2013

US generic and specialty drugmaker Watson Pharmaceuticals (NYSE: WPI) says that it has completed the…

Endo PharmaceuticalsGenericsGrunenthalMergers & AcquisitionsNeurologicalNorth AmericaOpanaPatentsPharmaceuticalUteron PharmaWatson PharmaceuticalsWomen's Health

FDA approves Protein Sciences egg-free flu vaccine Flublok; and Octapharma's Octaplas

18-01-2013

The US Food and Drug Administration revealed it has approved privately-held US biotech firm Protein Sciences…

Anti-viralsBiotechnologyFlublokMergers & AcquisitionsNorth AmericaOctapharmaOctaplasPanblokPharmaceuticalProtein Sciences CorpRegulationVaccines

Canada's Pharmascience sets up JV with Korea Kolmar; buys Rivex

03-01-2013

Privately-held Canadian drugmaker Pharmascience and Korea Kolmar Holdings, based in Seoul, South Korea,…

Asia-PacificBiotechnologyGenericsHelix BioPharmaKorea KolmarMergers & AcquisitionsNeurologicalNorth AmericaPharmaceuticalPharmascienceRivex Pharma

Recordati buys US portfolio of drugs from Lundbeck

17-12-2012

Italian drugmaker Recordati *RC: MI) has signed an agreement for the acquisition of all rights concerning…

LundbeckMergers & AcquisitionsNorth AmericaPharmaceuticalRare diseasesRecordati

Teva to raise stake in Rexahn; Pfizer completes NextWave deal

28-11-2012

US clinical-stage biopharma company focused on oncology and central nervous system (CNS) therapeutics…

Mergers & AcquisitionsNeurologicalNextWave PharmaceuticalsNorth AmericaOncologyPfizerPharmaceuticalQuillivantResearchRexahn PharmaceuticalsRX-3117Teva Pharmaceutical Industries

Bayer's Xarelto gets EU clearance for PE and prevention of DVT; gives up on Schiff acquisition

21-11-2012

Following swiftly on similar news from the US Food and Drug Administration, German drug major Bayer (BAYN:…

BayerCardio-vascularEuropeJanssenJohnson & JohnsonMergers & AcquisitionsNorth AmericaPharmaceuticalRegulationSchiff Nutrition InternationalXarelto

US FTC puts conditions on Novartis buy of Fougera

17-07-2012

The USA's Federal Trade Commission said yesterday that it will require Swiss drug major drug Novartis…

DermatologicalsFougera PharmaceuticalsGenericsMergers & AcquisitionsNeurologicalNorth AmericaNovartisPharmaceuticalTolmar

GlaxoSmithKline pulls sNDA for Tykerb plus Herceptin; Watson/Actavis update

13-07-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) revealed yesterday that it has withdrawn a supplemental New…

ActavisGenericsGlaxoSmithKlineHerceptinMergers & AcquisitionsNorth AmericaOncologyPharmaceuticalRegulationRocheTykerbWatson Pharmaceuticals

1 to 25 of 37 results

Parexel

Parexel

Back to top